<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">Examining the multifarious mechanisms through which SARS-CoV-2 increases morbidity in people with diabetes shows us that the relationship is complex, and is a testament to the fact that we are misplacing our resources attempting to fast-track targeted therapeutics, which may chip away at some detrimental inflammation in infected patients, but do little to foundationally improve metabolic and immune resilience against this pandemic or future ones.</p>
